|

HS-10382(Part 1: Dose escalation) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Jiangsu Hansoh Pharmaceutical Co., Ltd.1

Indications

  • CML, Accelerated Phase1
  • CML, Chronic Phase1
  • Cancer1

Other1 trial

A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.